ARCHIVES

FDA Advisors Okay NCI Toxicology Proposals, Write New Clinical Guidelines, Approve AIN DA

This article is from The Cancer Letter archive.

Vol. 05 No. 42 | October 19, 1979

Download PDF Visit The Full Archive

Related Articles

FDA Approves Rituxan For CLL

February 19, 2010

October issue of Business & Regulatory Report included.

November 5, 2004

Full Funding Of Indirect Costs, Other Mandates By Congress Chew Up Most Of NCI’s Extra Money

December 2, 1983

Guest Editorial: MD Anderson’s Judith Smith Questions NCI Short-Term Remedy For Carboplatin Dosing

October 15, 2010

RFP: Sole Source

May 12, 2000

NCI CTEP Approved Trials For the Month of April

April 25, 2014